Cover Story
By Matthew Bin Han Ong
In his first talk to NCI staff, director Norman “Ned” Sharpless presented himself as an institute insider—highlighting his career-long relationships with NCI and its “legends,” demonstrating his grasp of the institute's agenda and research portfolio.
In Brief
Drugs & Targets
Trending Stories
- Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S. - GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference
- How the 2024 elections can impact cancer policy
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- FDA extends shelf-life for IV fluids in shortage after Hurricane Helene